Acamprosate Safe to Use in Individuals With Liver Disease.
Condition(s):Alcohol-related Liver DiseaseLast Updated:December 20, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Alcohol-related Liver DiseaseLast Updated:December 20, 2022Completed
Condition(s):AlcoholismLast Updated:January 30, 2008Completed
Condition(s):AlcoholismLast Updated:May 3, 2010Completed
Condition(s):AlcoholismLast Updated:July 3, 2012Completed
Condition(s):Alcohol DependenceLast Updated:February 16, 2007Completed
Condition(s):Depressive Disorder, Major; AlcoholismLast Updated:August 5, 2020Unknown status
Condition(s):AlcoholismLast Updated:June 27, 2008Completed
Condition(s):Obsessive Compulsive DisorderLast Updated:December 1, 2009Completed
Condition(s):Drug-induced Tardive DyskinesiaLast Updated:April 13, 2021Withdrawn
Condition(s):Alcohol Use DisorderLast Updated:May 11, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.